Rosario never felt like a patient.
As a Hematology product specialist for Bristol Myers Squibb in Monterrey, Mexico, her focus is on helping patients. She works with business partners, institutions and teams of doctors to increase patient access to medicines that will improve their lives.
One Sunday in 2021, during a lunch date with a friend, Rosario, now 52, began her own journey as a patient.
That day, her legs were swollen. And they hurt. As someone who was otherwise in good health, this was a red flag for Rosario. She had also gained a few pounds that month, too — another red flag.
“That was strange because it’s very difficult for me to gain weight — I have always been skinny,” she said.
“Maybe you have a kidney infection,” her doctor-friend told her over lunch.
The next day, that friend conducted a few routine tests. Having worked for 25 years in the oncology and pharmaceutical industries, Rosario immediately understood the terminology in her test results.
Cancer.
Rosario was diagnosed with stage 2 stomach cancer. Now she was a patient.
The plan to stay alive
“When I read the results, I was at a meeting of all resident doctors and nurses at the University Hospital of Monterrey,” Rosario recalled. “I was in shock, but I couldn’t let myself cry. I didn’t feel like crying anyway. I had to plan what I was going to do to stay alive.”
“I jumped into action — I called my medical insurance and began researching ways of saving myself. This type of cancer can kill people within three months,” she said.
She knows this because she lost five family members to stomach cancer.
Rosario leaned in to her BMS network and secured an appointment with “the best oncologist in Monterrey,” who also happens to be a BMS employee. He informed her that she had a malignant tumor in her stomach that would need to be removed.
Rosario moved with urgency. She was able to schedule the surgery within a week and a half of diagnosis. She pre-paid for the procedure out of pocket, more than $11,000, because the wait to get authorization from her health insurance was too long.
“With stomach cancer, there is no time,” she said.
The impact of gastric cancer
More than one million people around the world are diagnosed with gastric cancer — or stomach cancer — each year. Survival rates vary based on many factors, including whether the cancer is still contained in the stomach or has spread. Treatment also varies from person to person based on a number of factors, and may include surgery, chemotherapy, radiation, targeted therapy, immunotherapy (such as checkpoint inhibitors) or a combination of treatments.
BMS has pioneered the checkpoint inhibition field, and is the only company with three approved checkpoint inhibitors (in the United States) to treat more than 10 types of cancer, including one for advanced stages of certain gastric cancers.
Race to the operating room
Prior to surgery, Rosario informed her son and daughter, who are the “engine” that keeps her running, of her diagnosis and treatment, which was, “an exceedingly difficult conversation to have.”
She scrambled to close pending projects at work because, “I didn’t know what was going to happen to me.” Her BMS colleagues and manager told her to drop everything and focus on herself. “But I just had to make sure everything was in order before I went into the operating room.”
Rosario underwent surgery and had 80% of her stomach removed. After 10 days in intensive care, she followed an aggressive chemotherapy and radiotherapy schedule, with breaks for rest, for a total of 12 weeks.
“I didn’t feel like a cancer patient, and I did not feel like I was dying,” Rosario said. "I stayed very strong during the treatment.”
Subscribe to Our stories alerts
Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and innovation, Our stories offer a window into the work our employees do every day for patients.
What to know about gastric cancer:
- Gastric cancer, or stomach cancer, falls under gastrointestinal cancers, which also includes colorectal, esophageal and liver cancer.
- Gastric cancer is the fifth most common cancer globally, with more than 1 million cases diagnosed annually.
- More than 95% of stomach cancers are adenocarcinoma, which develops in the cells that form the innermost lining of the stomach.
- Stomach cancer is nearly twice as common in men as in women.
- Gastric cancer mostly affects older people: 6 out of every 10 people diagnosed with stomach cancer are 65 or older.
Not broken, but reborn
Two years later, life looks a little different for Rosario. She gets tired more easily. She lost 40 pounds from her already petite frame. “The weight of my suitcase with a laptop and iPad has actually knocked me to the ground during work trips,” she said.
But she is happy. She finds peace and healing through her art. After many years as a painter, Rosario pivoted 12 years ago to working with glass and her pieces are planned for exhibit in nine museums and galleries across the Americas and Europe. She uses her art to tell her story.
“Glass is very fragile, but at the same time, it’s extraordinarily strong. It can be recycled, reassembled, reborn. Human beings, just like glass, can break, and we can be put back together and become indestructible,” she said.
Her art is healing for others, as well.
“What fills me with satisfaction is that I can support people through my art. I call them healing pieces. I have seen people examine my work and cry when they see themselves in the pieces and say, ‘That’s me, I broke down and came back stronger.’ I want them to know cancer does not have to mean death. You can pick up your little pieces, stick them back together and make yourself stronger, wiser and more beautiful.”
A new perspective
Rosario is currently under observation, and undergoes a PET scan four times a year, due to the aggressive nature of her disease. She uses her experience to enhance the commitment she already had to patients long before her diagnosis.
“I have always been very committed to ensuring that patients have the treatment they need. But now, I have lived as a patient and can speak as a patient,” Rosario said.
“BMS is working to ensure patients are well and can spend more time with their families,” she added. “I’m able to support clients, and I’m able to give love through others and give hope.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.